Even people who don’t follow the local biotech industry know that our largest locally-owned firm, Biogen Idec, has had a great last couple of years.
The Cambridge drug company launched one of the biggest blockbuster drugs anywhere in 2013, Tecfidera, for the treatment of multiple sclerosis. That helped catapult the 7,300-employee company to become the most valuable publicly-traded company in the state as measured by market capitalization. It’s also led to a 40 percent increase in revenue for the most recent 12-month period for which Biogen (Nasdaq: BIIB) has reported. (its second quarter ended June 30).
Help employers find you! Check out all the jobs and post your resume.
